Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.
Front Pharmacol. 2024 Feb 20;15:1334233. doi: 10.3389/fphar.2024.1334233. eCollection 2024.
Front Pharmacol. 2024.
PMID: 38444946
Free PMC article.
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial.
von Einem JC, Heinemann V, von Weikersthal LF, Vehling-Kaiser U, Stauch M, Hass HG, Decker T, Klein S, Held S, Jung A, Kirchner T, Haas M, Holch J, Michl M, Aubele P, Boeck S, Schulz C, Giessen C, Stintzing S, Modest DP.
von Einem JC, et al. Among authors: aubele p.
J Cancer Res Clin Oncol. 2014 Sep;140(9):1607-14. doi: 10.1007/s00432-014-1678-3. Epub 2014 May 10.
J Cancer Res Clin Oncol. 2014.
PMID: 24816724
Free PMC article.
Clinical Trial.
Item in Clipboard
Thrombin-induced shedding of tumour endothelial marker 5 and exposure of its RGD motif are regulated by cell-surface protein disulfide-isomerase.
Vallon M, Aubele P, Janssen KP, Essler M.
Vallon M, et al. Among authors: aubele p.
Biochem J. 2012 Feb 1;441(3):937-44. doi: 10.1042/BJ20111682.
Biochem J. 2012.
PMID: 22013897
Item in Clipboard
A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.
Giessen C, von Weikersthal LF, Hinke A, Stintzing S, Kullmann F, Vehling-Kaiser U, Mayerle J, Bangerter M, Denzlinger C, Sieber M, Teschendorf C, Freiberg-Richter J, Schulz C, Modest DP, Moosmann N, Aubele P, Heinemann V.
Giessen C, et al. Among authors: aubele p.
BMC Cancer. 2011 Aug 23;11:367. doi: 10.1186/1471-2407-11-367.
BMC Cancer. 2011.
PMID: 21861888
Free PMC article.
Clinical Trial.
Item in Clipboard
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
Modest DP, Stintzing S, Laubender RP, Neumann J, Jung A, Giessen C, Haas M, Aubele P, Schulz C, Boeck S, Stemmler HJ, Kirchner T, Heinemann V.
Modest DP, et al. Among authors: aubele p.
Anticancer Drugs. 2011 Oct;22(9):913-8. doi: 10.1097/CAD.0b013e3283493160.
Anticancer Drugs. 2011.
PMID: 21795973
Clinical Trial.
Item in Clipboard
Cite
Cite